ALK-Abelló
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
ALK | CO
Overview
Corporate Details
- ISIN(s):
- DK0061802139
- LEI:
- 529900SGCREUZCZ7P020
- Country:
- Denmark
- Address:
- Bøge Alle 6-8, 2970 Hørsholm
- Website:
- https://www.alk.net
- Sector:
- Manufacturing
Description
ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-21 18:43 |
ALK upgrades its full-year revenue and earnings outlook
|
Danish | HTML • 4.3 KB | ||
| 2024-06-21 18:38 | English | HTML • 4.1 KB | |||
| 2024-06-21 18:38 | Danish | HTML • 4.5 KB | |||
| 2024-06-21 18:38 |
ALK provides update on regulatory process for the house dust mite allergy table…
|
Danish | PDF • 152.6 KB | ||
| 2024-06-21 18:38 |
ALK provides update on regulatory process for the house dust mite allergy table…
|
Danish | PDF • 169.1 KB | ||
| 2024-06-03 18:02 | Danish | PDF • 277.0 KB | |||
| 2024-06-03 18:02 | English | HTML • 13.6 KB | |||
| 2024-06-03 18:02 |
ALK launches new growth strategy and 2028 financial ambitions
|
Danish | HTML • 14.4 KB | ||
| 2024-06-03 18:02 |
ALK launches new growth strategy and 2028 financial ambitions
|
Danish | PDF • 295.4 KB | ||
| 2024-05-02 19:26 | Danish | PDF • 164.9 KB | |||
| 2024-05-02 19:26 | English | PDF • 163.5 KB | |||
| 2024-05-02 19:26 |
ALK upgrades its full-year revenue outlook
|
Danish | HTML • 3.1 KB | ||
| 2024-05-02 19:26 |
ALK upgrades its full-year revenue outlook
|
Danish | HTML • 2.6 KB | ||
| 2024-03-05 16:45 | Danish | HTML • 1.6 KB | |||
| 2024-03-05 16:45 | English | PDF • 146.2 KB |
Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALK-Abelló
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALK-Abelló via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
